Billing code 96417: Chemotherapy infusionMedicare rate & RVUs in Florida
Reports an additional sequential intravenous infusion of a different chemotherapy drug or substance, following a primary chemotherapy infusion service.
Medicare pays $64.40–$70.40 for 96417 in the office in Florida, from Rest Of Florida to Miami. Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
On this page 9 sections
What 96417 covers
This code represents an additional sequential intravenous infusion of a different chemotherapy drug or substance, generally administered by clinical staff in an oncology office or infusion setting. The next drug is given in sequence rather than concurrently with the preceding infusion. It is distinct from extra time spent continuing the same drug and from chemotherapy delivered by injection or prolonged pump infusion.
Report it as an add-on with the primary chemotherapy administration service when documentation supports a separate sequential infusion of another drug. The medication administration record and infusion documentation should identify the drugs and show their sequence and administration times. For Medicare, this add-on is paid within the primary procedure's global period. CMS classifies it as an incident-to service, so it is billed only when performed under physician supervision.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where 96417 pays more and less in Florida
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
3 payment localities
$64.40 to $70.40
| Payment locality | Office | Facility |
|---|---|---|
| Fort Lauderdale | $68.04 | Unavailable |
| Miami | $70.40 | Unavailable |
| Rest Of Florida | $64.40 | Unavailable |
How the 96417 rate is calculated
Each of 96417’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · 96417
RVUs × geographic indexes × conversion factor
Work0.21
0.21 RVUs× 1.000 GPCI
Practice expense1.75
1.75 RVUs× 1.000 GPCI
Malpractice0.03
0.03 RVUs× 1.000 GPCI
Adjusted RVUs
1.9900
Conversion factor
$33.4009
Medicare rate
$66.47
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for 96417
The CMS indicators that decide how 96417 is paid alongside other services.
CMS payment indicators · 96417
Chemotherapy infusion
| Rule | CMS value | What it means |
|---|---|---|
| Global period | ZZZ | Add-on code: falls within the primary procedure’s global period. |
| Multiple procedures | 0 | No multiple-procedure reduction. |
| Bilateral (modifier 50) | 0 | The 150% bilateral adjustment doesn’t apply. |
| Assistant at surgery (80/81/82/AS) | 0 | Not paid without supporting documentation. |
| Co-surgeons (62) | 0 | Not permitted. |
| Team surgery (66) | 0 | Not permitted. |
| Professional/technical | 5 | Incident-to service. |
96417 compared with similar codes
Compare codes · National
5 codes, side by side
How to choose
- 96413Chemo IV infusion
- 96413 reports the primary intravenous chemotherapy infusion. Use 96417 for an additional different drug infused sequentially after that primary service.
- 96415Chemo infusion add-on
- 96415 reports additional time when an infusion continues; 96417 represents a separate sequential infusion of a different drug or substance.
- 96411IV chemotherapy push
- 96411 is for an additional chemotherapy drug administered by intravenous push. 96417 is for a different drug given as a sequential infusion.
- 96416Pump infusion
- 96416 describes prolonged chemotherapy infusion using a pump. 96417 identifies an additional sequential infusion of a different drug.
96417 billing questions
When is 96417 reported with 96413?
Report 96417 for an additional sequential infusion of a different chemotherapy drug after the primary infusion service. It is an add-on and cannot stand alone.
Is 96417 for extra time with the same drug?
No. It represents a sequential infusion of a different drug or substance; 96415 is used for additional infusion time when the same infusion continues.
Can 96417 describe a concurrent infusion?
No. The additional drug must be infused sequentially, not concurrently with the preceding infusion.
What documentation supports a unit of 96417?
Document the additional drug, its sequential administration, and the infusion times in the medication administration and infusion records. The service represents an additional sequential infusion, not another hour of the same infusion.
What supervision is required for Medicare billing?
CMS classifies 96417 as an incident-to service. It is billed only when performed under physician supervision.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets
Put 96417 and the rest of your codes on one sheet
Build a fee sheet from your own code list at your locality, put your payer contracts beside Medicare, and see what changed each quarter.
Build my fee sheetOr price your code list free →